AP Biosciences, Inc.

NT$112.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6945Healthcare
Country Taiwan
PE (Fwd) •••
TSR 3Y CAGR 18.02%
Div yield —
ROE (24.52%)
Biotechnology
Beta (5Y) (0.29)
PE TTM —
TSR TTM (0.44%)
Mkt cap NT$10.92B
ROIC (16.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$135
20.27%
(30.66%)
Hold 11|1|3|3|6
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
2.52
2.53
2.49
2.75
13.90%
19.65%
9.86%
11.84%
RevenueNT$B
1.173
1.142
1.202
1.201
(2.62%)
(7.35%)
(3.27%)
(0.59%)
Peers (US$329.9M)
Cap (US$)
PE
328.9M
—
Capital
TTM
5Y
10Y
Leveragex
1.487
(0.117)
(0.126)
EBIT/Intx
5.437
0.410
0.322
Own earn%
(2.96)
48.31
48.22
Sh yield%
31.16
18.04
17.40
Owners
Insiders/Inst%
14.42
79.80
Short interest%
3.36
SBC / revenue%
4.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
5–9
$1 testx
—
Incr. ROIC%
5